US healthcare spending soars to over $5 trillion in 2024
News

US healthcare spending soars to over $5 trillion in 2024

U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion in 2023, driven by ...

Novo Nordisk's US public affairs head leaves company, memo shows
News

Novo Nordisk's US public affairs head leaves company, memo shows

Danish obesity drugmaker Novo Nordisk's head of public affairs in the U.S. has left the company, acc ...

Alcon Sweetens Its Bid to Buy Rival STAAR Surgical in $1.6 Billion Deal
News

Alcon Sweetens Its Bid to Buy Rival STAAR Surgical in $1.6 Billion Deal

Swiss eyecare giant Alcon has dramatically boosted its takeover bid for U.S. medical technology firm ...

Bird flu poses risk of pandemic worse than COVID, France's Institut Pasteur says
News

Bird flu poses risk of pandemic worse than COVID, France's Institut Pasteur says

The bird flu virus that has been spreading among wild birds, poultry and mammals could lead to a pan ...

August Global Partners closes $150 million healthcare fund, lifts assets to $350 million
News

August Global Partners closes $150 million healthcare fund, lifts assets to $350 million

Singapore-based healthcare and technology investor August Global Partners has closed its flagship he ...

Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push
News

Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push

Eli Lilly said on Wednesday it will invest more than $1.2 billion to expand its manufacturing site i ...

CBC Group raises $500 million for Asia's largest healthcare private credit fund
Business

CBC Group raises $500 million for Asia's largest healthcare private credit fund

CBC Group, Asia's largest healthcare focused asset manager, has raised $500 million for its second R ...

Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
Business

Eli Lilly to invest over $1 billion in India to expand manufacturing capacity

Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and s ...

U.S. Vaccine Panel Reverses Course, Now Emphasizes Doctor-Patient Decision Making for COVID Shots
News

U.S. Vaccine Panel Reverses Course, Now Emphasizes Doctor-Patient Decision Making for COVID Shots

In a notable departure from previous policy, a U.S. advisory committee has abandoned its blanket rec ...

Europe on Alert as Trump’s Drug Pricing Mandate Sends Shockwaves Through Global Pharma
News

Europe on Alert as Trump’s Drug Pricing Mandate Sends Shockwaves Through Global Pharma

European capitals are on edge following a bold executive order from former U.S. President Donald Tru ...

Siemens Healthineers Warns of Up to $340 Million Tariff Blow in Second Half of 2025
News

Siemens Healthineers Warns of Up to $340 Million Tariff Blow in Second Half of 2025

Siemens Healthineers is bracing for a significant financial hit of up to euro 300 million ($341 mill ...

U.S. actions may set polio eradication back, WHO says
News

U.S. actions may set polio eradication back, WHO says

The eradication of polio as a global health threat may be delayed unless U.S. funding cuts - potenti ...

Tariffs should not dictate how Indian drugmakers do business, Cipla CEO says
Business

Tariffs should not dictate how Indian drugmakers do business, Cipla CEO says

Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Frida ...

Trump signs healthcare price transparency executive order
News

Trump signs healthcare price transparency executive order

U.S. President Donald Trump signed an executive order on Tuesday aiming to improve price transparenc ...

Indian drugmakers likely to be hit as Trump plans pharmaceutical import tariffs
Business

Indian drugmakers likely to be hit as Trump plans pharmaceutical import tariffs

U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semicon ...

Healthcare dealmakers eye M&A resurgence in second Trump term
News

Healthcare dealmakers eye M&A resurgence in second Trump term

Healthcare dealmakers gathering in San Francisco for the industry's premier annual conference this w ...

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln
Business

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimenta ...

Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production
News

Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of ...

Novo Nordisk Pharmatech unit to build $220 mln plant in Denmark
News

Novo Nordisk Pharmatech unit to build $220 mln plant in Denmark

Novo Nordisk's Pharmatech unit will build a 1.5 billion Danish crowns ($220.83 million) plant in Den ...

Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high
Business

Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high

Cipla, India's third-largest generics drugmaker by sales, beat first-quarter profit estimates on Fri ...

Pharma aims to deliver personalised cancer therapies more quickly
News

Pharma aims to deliver personalised cancer therapies more quickly

Big pharmaceutical companies that make personalised blood cancer treatments are working to cut the m ...

Australia's Telix Pharma to raise $398 mln in debt to fund cancer therapy
News

Australia's Telix Pharma to raise $398 mln in debt to fund cancer therapy

Telix Pharmaceuticals aims to raise A$600 million ($397.5 million) via the issue of convertible note ...

Healthcare firm Concentra eyes $3.3 bln valuation in US IPO
Business

Healthcare firm Concentra eyes $3.3 bln valuation in US IPO

Concentra Group, a Select Medical unit, is eyeing a valuation of $3.30 billion in its U.S. initial p ...

US FTC to sue drug middlemen over insulin prices, source says
News

US FTC to sue drug middlemen over insulin prices, source says

The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over their t ...

India's Emcure Pharma jumps 35% in debut trade at $223 mln valuation
Business

India's Emcure Pharma jumps 35% in debut trade at $223 mln valuation

Indian drugmaker Emcure Pharmaceuticals' shares rose 34.9 per cent in debut trade on Wednesday, beat ...

Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital
Business

Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital

Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go public ...

Sanofi-backed Formation Bio raises $372 million in late-stage funding round
Business

Sanofi-backed Formation Bio raises $372 million in late-stage funding round

AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-st ...

China's Fosun offers to buy out Henlius Biotech, valuing drugmaker at $1.71 bln
Business

China's Fosun offers to buy out Henlius Biotech, valuing drugmaker at $1.71 bln

Chinese conglomerate Fosun International will buy the remaining stake in Shanghai Henlius Biotech it ...

AbbVie inks immune disorder drug licensing deal with China's FutureGen
Business

AbbVie inks immune disorder drug licensing deal with China's FutureGen

U.S. drugmaker AbbVie will develop and commercialize an experimental treatment for inflammatory bowe ...

India's pharma export sales to grow faster this year, trade body says
News

India's pharma export sales to grow faster this year, trade body says

India's pharmaceutical export sales growth is expected to pick up to nearly 11% this fiscal year, fr ...

BioNTech gets $145 mln funding for African vaccine plants
News

BioNTech gets $145 mln funding for African vaccine plants

COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from a global coalition ag ...

India's MedPlus Health posts over 25% rise in Q4 profit on strong retail sales
Business

India's MedPlus Health posts over 25% rise in Q4 profit on strong retail sales

India's MedPlus Health Services reported a rise in fourthquarter profit on Tuesday, driven by retail ...

Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
Business

Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars

Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufactur ...

Medtronic beats quarterly profit estimates on medical devices strength
News

Medtronic beats quarterly profit estimates on medical devices strength

Health tech firm Medtronic beat Wall Street estimates for quarterly profit and revenue on Thursday, ...

India's Gland Pharma misses Q4 profit view on higher employee costs
News

India's Gland Pharma misses Q4 profit view on higher employee costs

Indian generic injectables maker Gland Pharma reported fourth-quarter profit below estimates on Wedn ...

Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln
News

Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln

German packaging and medical equipment maker Gerresheimer said on Thursday it signed a purchase agre ...

AstraZeneca aims for $80 bln in total revenue by 2030
News

AstraZeneca aims for $80 bln in total revenue by 2030

AstraZeneca aims to grow revenue by about 75 per cent to $80 billion by 2030, it said on Tuesday, bo ...

Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
News

Sanofi partners with OpenAI, Formation Bio on AI-driven drug development

French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence compan ...

Elon Musk, Indonesian health minister, launch Starlink for health sector
Business

Elon Musk, Indonesian health minister, launch Starlink for health sector

Elon Musk and Indonesian Health Minister Budi Gunadi Sadikin launched SpaceX's satellite internet se ...

AstraZeneca to build $1.5-bln cancer drug plant in Singapore
News

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising ...

GSK raises $1.5 bln from sale of remaining Haleon stake
Business

GSK raises $1.5 bln from sale of remaining Haleon stake

British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining st ...

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
News

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France wo ...

Novavax shares soar on license deal with Sanofi at lofty valuation
Business

Novavax shares soar on license deal with Sanofi at lofty valuation

Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for it ...

India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
News

India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says

Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatmen ...

India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Business

India's Alembic Pharma posts higher Q4 profit on strong N.America sales

Indian generic drugmaker Alembic Pharma reported a 17 per cent rise in fourth-quarter profit on Thur ...

Uttarakhand accuses Patanjali's Ramdev of misleading public with COVID, other cures
Business

Uttarakhand accuses Patanjali's Ramdev of misleading public with COVID, other cures

An Indian state has accused yoga guru Baba Ramdev of criminal misconduct for promoting his tradition ...

India's Dr Reddy's beats Q4 profit view on higher US, Europe sales
News

India's Dr Reddy's beats Q4 profit view on higher US, Europe sales

India's generic drugmaker Dr Reddy's Laboratories reported fourth-quarter profit above expectations ...

Japan's Ono to buy US drugmaker Decipher for $2.4 bln
News

Japan's Ono to buy US drugmaker Decipher for $2.4 bln

Deciphera Pharmaceuticals said on Monday Japan's Ono Pharmaceutical Co will acquire the cancer drugm ...

About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
News

About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows

About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare ...

Bristol Myers signs $380 mln CAR-T therapies supply deal with Cellares
News

Bristol Myers signs $380 mln CAR-T therapies supply deal with Cellares

Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract manufacturer Cel ...

Healthcare firm PACS Group's shares rise nearly 10% in NYSE debut
Business

Healthcare firm PACS Group's shares rise nearly 10% in NYSE debut

PACS Group shares rose nearly 10 per cent in their debut on the New York Stock Exchange on Thursday, ...

Morgan Stanley pledges $20 million for children's mental health initiative
News

Morgan Stanley pledges $20 million for children's mental health initiative

Morgan Stanley pledged $20 million over five years to its children's mental health initiative, bring ...

Novartis taps Arvinas' cancer drug for up to $1 billion
News

Novartis taps Arvinas' cancer drug for up to $1 billion

Swiss drugmaker Novartis AG has entered into a licensing deal worth up to $1.01 billion with Arvinas ...

J&J boosts heart device business with $12.5 bln Shockwave Medical deal
News

J&J boosts heart device business with $12.5 bln Shockwave Medical deal

Johnson & Johnson on Friday agreed to buy Shockwave Medical for $12.5 billion, in a deal that wo ...

US takes next step in Medicare drug price negotiations with pharma companies 
Business

US takes next step in Medicare drug price negotiations with pharma companies 

The Biden administration said on Tuesday it has responded to offers from the manufacturers of 10 hig ...

UnitedHealth unit hack may hit pharmacies, providers' credit profiles, Fitch says
Business

UnitedHealth unit hack may hit pharmacies, providers' credit profiles, Fitch says

Ratings agency Fitch said on Monday some smaller healthcare providers and pharmacies that use its se ...

AstraZeneca bets on new cancer treatments with $2 bln Fusion Pharma purchase
Business

AstraZeneca bets on new cancer treatments with $2 bln Fusion Pharma purchase

AstraZeneca said on Tuesday it will buy clinicalstage biopharmaceutical company Fusion Pharmaceutica ...

AstraZeneca to cap US out-of-pocket costs for inhalers at $35 per month
News

AstraZeneca to cap US out-of-pocket costs for inhalers at $35 per month

AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at ...

AstraZeneca targets 2024 growth as portfolio booms
News

AstraZeneca targets 2024 growth as portfolio booms

AstraZeneca expects to boost revenue and profit this year on the back of resilient demand for its ca ...

Indian drugmaker Lupin beats quarterly profit estimates on strong demand
News

Indian drugmaker Lupin beats quarterly profit estimates on strong demand

Indian generic drugmaker Lupin reported a bigger-thanexpected rise in its third-quarter profit on We ...

Fractyl Health targets up to $762 mln valuation in US IPO
News

Fractyl Health targets up to $762 mln valuation in US IPO

Obesity and diabetes drug developer Fractyl Health said on Monday it was aiming for a market valuati ...

France's Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 bln
News

France's Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 bln

French healthcare company Sanofi has agreed to buy the drug development project INBRX-101 from its p ...

India's Cipla Q3 profit tops estimates on North America sales boost
News

India's Cipla Q3 profit tops estimates on North America sales boost

Indian generic drugmaker Cipla on Monday reported its third-quarter profit above analysts expectatio ...

Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mn
Business

Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mn

India's Sun Pharmaceutical Industries Limited said on Wednesday it would buy all the shares of Taro ...

Weight loss drug windfall attracts pharma companies
News

Weight loss drug windfall attracts pharma companies

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity mark ...

Merck in talks to buy Harpoon Therapeutics for around $700 mln
Business

Merck in talks to buy Harpoon Therapeutics for around $700 mln

Merck & Co is in advanced talks to buy cancer drugmaker Harpoon Therapeutics Inc for around $700 ...

Bristol Myers strikes $4.1 bln RayzeBio deal for targeted cancer therapies
News

Bristol Myers strikes $4.1 bln RayzeBio deal for targeted cancer therapies

Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its can ...

AstraZeneca to buy China's Gracell Biotechnologies in $1.2 bln deal
News

AstraZeneca to buy China's Gracell Biotechnologies in $1.2 bln deal

AstraZeneca said on Tuesday it will buy Gracell Biotechnologies for up to $1.2 billion as the Anglo- ...

India's big hospital chains think small to expand in booming market
News

India's big hospital chains think small to expand in booming market

India's prominent hospital chains are shifting their focus to smaller centres and facilities as they ...

Novo owner commits $265 mln of Wegovy windfall to respiratory diseases
News

Novo owner commits $265 mln of Wegovy windfall to respiratory diseases

The Novo Nordisk Foundation, which controls drug maker Novo Nordisk, said on Monday it would commit ...

U.S. healthcare spending rises to $4.5 trillion
News

U.S. healthcare spending rises to $4.5 trillion

Healthcare spending in the United States rose 4.1 per cent in 2022 to $4.5 trillion, federal data sh ...

Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights
News

Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights

Pfizer said on Tuesday it expects to close its $43 billion deal to buy cancer drugmaker Seagen& ...

AstraZeneca, AI biologics firm Absci tie up on cancer drug
News

AstraZeneca, AI biologics firm Absci tie up on cancer drug

Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial ...

AbbVie signs $10 bln deal to buy cancer drugmaker ImmunoGen
Business

AbbVie signs $10 bln deal to buy cancer drugmaker ImmunoGen

AbbVie said on Thursday it will buy ImmunoGen for $10.1 billion, underscoring a growing interest fro ...

Pharma giants warn of 'chaos' in venue fight over US price-fixing cases
News

Pharma giants warn of 'chaos' in venue fight over US price-fixing cases

Major pharmaceutical firms are trying to bar a group of states that sued them from leaving centraliz ...

Sanofi looks to widen Dupixent use to treat 'smoker's lung' after second trial win
News

Sanofi looks to widen Dupixent use to treat 'smoker's lung' after second trial win

Sanofi plans to seek U.S. approval for it best-selling antiinflammatory drug Dupixent to be used in ...

Indian drug manufacturers benefit from Big Pharma interest beyond China
News

Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clin ...

UK drugmakers, government agree renewed revenue clawback scheme
News

UK drugmakers, government agree renewed revenue clawback scheme

Britain's pharmaceutical industry and the government have agreed terms to renew a medicines access s ...

Novo Nordisk to invest $6 bln in Denmark expansions
News

Novo Nordisk to invest $6 bln in Denmark expansions

Novo Nordisk said on Friday it will invest more than 42 billion Danish crowns ($6 billion) from 2023 ...

US FDA warns Amazon against sale of unapproved eye drops
Business

US FDA warns Amazon against sale of unapproved eye drops

The US Food and Drug Administration said on Tuesday it had sent a warning letter to Amazon.com relat ...

IHH Healthcare unit sues Japan's Daiichi Sankyo over Fortis deal
News

IHH Healthcare unit sues Japan's Daiichi Sankyo over Fortis deal

Malaysia's IHH Healthcare on Tuesday said its unit filed a claim against Japan's Daiichi Sankyo in m ...

Novo Nordisk to invest $6 bln in Denmark expansions
News

Novo Nordisk to invest $6 bln in Denmark expansions

Novo Nordisk said on Friday it will invest more than 42 billion Danish crowns ($6 billion) from 2023 ...

AstraZeneca ups profit outlook on strong cancer drugs demand
News

AstraZeneca ups profit outlook on strong cancer drugs demand

AstraZeneca raised its annual earnings forecast on Thursday, helped by strong demand for its cancer ...

India's Zydus Wellness profit drops on one-off deferred tax expense
Business

India's Zydus Wellness profit drops on one-off deferred tax expense

Indian consumer good company Zydus Wellness reported a more than 30 per cent drop in second-quarter ...

EU proposal may accelerate pharma innovation decline, industry group says
News

EU proposal may accelerate pharma innovation decline, industry group says

A major pharmaceutical rules overhaul, proposed by the European Commission in April, could see Europ ...

Moderna revenue tops expectations, expects to return to sales growth in 2025
Business

Moderna revenue tops expectations, expects to return to sales growth in 2025

Moderna on Thursday said it expected 2023 revenue of at least $6 billion, a decline reflecting weake ...

Japan's Astellas halves profit forecast after Iveric Bio purchase
Business

Japan's Astellas halves profit forecast after Iveric Bio purchase

Japan's Astellas Pharma cut its full-year profit forecast by more than half on Wednesday, citing eff ...

AstraZeneca to invest $245 mln in Cellectis to boost gene therapy prospects
News

AstraZeneca to invest $245 mln in Cellectis to boost gene therapy prospects

AstraZeneca said on Wednesday it would invest $245 million in French biotechnology company Cellectis ...

Novartis drug candidate scores interim win in rare kidney disease trial
News

Novartis drug candidate scores interim win in rare kidney disease trial

Novartis said its experimental drug atrasentan was shown to have a positive effect on an indicator o ...

Indian drugmaker Cipla tops Q2 profit view on solid domestic, N.America sales
Business

Indian drugmaker Cipla tops Q2 profit view on solid domestic, N.America sales

Cipla, India's third-largest generic drugmaker by sales, posted a bigger-than-expected rise in secon ...

Roche buys Telavant Holdings for $7.1 billion
Business

Roche buys Telavant Holdings for $7.1 billion

Roche on Monday said it will buy Telavant, a developer of a new treatment for inflammatory bowel dis ...

Royalty Pharma to pay $1 bln for Roche's SMA drug royalties
News

Royalty Pharma to pay $1 bln for Roche's SMA drug royalties

Royalty Pharma said on Thursday it has purchased additional royalties on Roche and PTC Therapeutics' ...

GSK signs shingles vaccine deal with China's Zhifei for around $3 bln
Business

GSK signs shingles vaccine deal with China's Zhifei for around $3 bln

China's largest vaccines company Zhifei will pay British drugmaker GSK 2.5 billion pounds ($3.05 bil ...

India finds more toxic syrups mont after poisoning deaths
Business

India finds more toxic syrups mont after poisoning deaths

India's drug regulator has found that a cough syrup and an anti-allergy syrup made by Norris Medicin ...

Drugmakers sign on to negotiate Medicare prices under protest
News

Drugmakers sign on to negotiate Medicare prices under protest

All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiati ...

Takeda announces voluntary withdrawal of lung cancer therapy
News

Takeda announces voluntary withdrawal of lung cancer therapy

Japan's Takeda Pharmaceutical said on Monday it will voluntarily withdraw its lung cancer therapy fr ...

Novo Nordisk India head eyes 2026 Wegovy launch, warns against copycats
News

Novo Nordisk India head eyes 2026 Wegovy launch, warns against copycats

Danish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026 ...

Gritstone bio wins $433 million US contract for COVID vaccine study
News

Gritstone bio wins $433 million US contract for COVID vaccine study

Gritstone bio on Wednesday secured a $433 million contract by the U.S. government to conduct a mid-s ...

Big Pharma bets on AI to speed up clinical trials
News

Big Pharma bets on AI to speed up clinical trials

Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or ...

India to mandate annual audit of pharma suppliers by drugmakers
News

India to mandate annual audit of pharma suppliers by drugmakers

India will make it mandatory for drugmakers to audit their raw material suppliers at least once a ye ...

GE HealthCare gets $44 mln grant to develop AI-assisted ultrasound tech
News

GE HealthCare gets $44 mln grant to develop AI-assisted ultrasound tech

GE HealthCare Technologies Inc has received a grant of more than $44 million from the Bill & Mel ...

BioNTech partners with CEPI to advance development of mpox vaccine
News

BioNTech partners with CEPI to advance development of mpox vaccine

Germany's BioNTech said on Monday it is entering into a partnership with the Coalition for Epidemic ...

Medical equipment firm Rotech Healthcare explores sale - sources
Business

Medical equipment firm Rotech Healthcare explores sale - sources

Rotech Healthcare Inc is exploring a possible sale that could value the provider of home medical equ ...

India's Concord Biotech up 33 per cent in debut, nets over $1 billion in valuation
Business

India's Concord Biotech up 33 per cent in debut, nets over $1 billion in valuation

Shares of India's Concord Biotech climbed as much as 33.3 per cent in their market debut on Friday, ...

Uzbekistan starts trial over 65 child deaths linked to contaminated cough syrups
News

Uzbekistan starts trial over 65 child deaths linked to contaminated cough syrups

Uzbekistan began a trial on Friday over the deaths last year of 65 children linked to contaminated c ...

India's Zydus Lifesciences more than doubles profit on US sales growth
Business

India's Zydus Lifesciences more than doubles profit on US sales growth

Indian generic drugmaker Zydus Lifesciences Ltd said on Friday its profit more than doubled in the f ...

India's Gland Pharma posts 41 per cent jump in quarterly revenue on Cenexi acquisition
Business

India's Gland Pharma posts 41 per cent jump in quarterly revenue on Cenexi acquisition

Indian generic injectables maker Gland Pharma Ltd reported a 41 per cent jump in first-quarter reven ...

WHO flags India-made syrup in latest warning over contaminated drugs
News

WHO flags India-made syrup in latest warning over contaminated drugs

The World Health Organization on Monday flagged a batch of contaminated common cold syrup, manufactu ...

Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio
News

Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio

Biogen said it would buy biotech firm Reata Pharmaceuticals for roughly $6.5 billion to expand its p ...

India to consider new drugs bill to regulate imports, manufacturing
News

India to consider new drugs bill to regulate imports, manufacturing

India's lawmakers will consider a new drugs bill next week on rules for importing, manufacturing and ...

Singapore-based Quadria Capital to invest up to $155 million in India's Maxivision Eye Hospital
Business

Singapore-based Quadria Capital to invest up to $155 million in India's Maxivision Eye Hospital

Singapore-based private equity firm Quadria Capital said on Wednesday it will invest up to $155 mill ...

China launches campaign to crack down on illegal fertility treatments
News

China launches campaign to crack down on illegal fertility treatments

China will "severely crack down"on illegal activities related to the use of assisted reproductive te ...

Novavax to receive $350 mln from Canada for unused COVID shots
News

Novavax to receive $350 mln from Canada for unused COVID shots

Novavax Inc said on Friday Canada will pay $349.6 million to settle the forfeiting of certain doses ...

India's Biocon Biologics launches biosimilar for AbbVie's Humira in U.S.
News

India's Biocon Biologics launches biosimilar for AbbVie's Humira in U.S.

India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster ...

EU secures vaccine deals with Pfizer, and others for future pandemic
Business

EU secures vaccine deals with Pfizer, and others for future pandemic

The European Commission has secured deals with Pfizer and several European drugmakers to reserve cap ...

China's CSPC Pharma partners with Pfizer for oral COVID treatment
News

China's CSPC Pharma partners with Pfizer for oral COVID treatment

Chinese drug maker CSPC Pharmaceutical Group said on Thursday it signed a strategic partnership with ...

iNova to buy Mundipharma's consumer healthcare brands for $540 mn
Business

iNova to buy Mundipharma's consumer healthcare brands for $540 mn

Singapore-headquartered iNova Pharmaceuticals will buy a portfolio of consumer healthcare brands fro ...

Threat of poisoning from Indian cough syrups persists around the world: WHO
News

Threat of poisoning from Indian cough syrups persists around the world: WHO

WHO lacks reliable evidence that Indian cough syrups, which have killed 300 children in various coun ...

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say
News

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of t ...

BioNTech faces first German lawsuit over alleged COVID vaccine side effects
News

BioNTech faces first German lawsuit over alleged COVID vaccine side effects

BioNTech will go to court on Monday to defend itself against a lawsuit from a German woman who is se ...

Novartis to acquire US-based Chinook for $3.2 bln upfront
Business

Novartis to acquire US-based Chinook for $3.2 bln upfront

Novartis said on Monday that it has entered in an agreement to acquire USbased Chinook Therapeutics ...

Australia's Estia Health soars on sweetened $552 mn bid from Bain Capital
Business

Australia's Estia Health soars on sweetened $552 mn bid from Bain Capital

Australia's Estia Health on Wednesday said it intended to back Bain Capital's sweetened takeover off ...

EU Commission allocates $1.3 bln to tackle mental health 'silent epidemic'
Business

EU Commission allocates $1.3 bln to tackle mental health 'silent epidemic'

The European Commission said on Wednesday it would allocate 1.23 billion euros ($1.3 billion) to men ...

Novavax exec says its new COVID shot should work against variants on the rise
News

Novavax exec says its new COVID shot should work against variants on the rise

Novavax Inc's (NVAX.O) head of research and development on Monday said an updated COVID-19 vaccine t ...

Drug developer Servier's brain cancer drug slows tumor progession considerably
News

Drug developer Servier's brain cancer drug slows tumor progession considerably

Private drug developer Servier Group said on Sunday its experimental brain cancer treatment has cons ...

Novo Nordisk in talks buy controlling stake in Biocorp
News

Novo Nordisk in talks buy controlling stake in Biocorp

Danish drug developer Novo Nordisk said on Monday it had started talks to buy a controlling stake in ...

Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
News

Novartis drug cuts recurrence risk by 25% in early-stage breast cancer

Novartis breast cancer drug Kisqali cut the risk of recurrence by a little more than 25 per cent in ...

FDA warns about safety risks of tailored weight-loss drugs
News

FDA warns about safety risks of tailored weight-loss drugs

The US Food and Drug Administration (FDA) warned about the safety risks of using compounded or custo ...

Japan PM orders $26 billion to be set aside for childcare, more debt may follow
Business

Japan PM orders $26 billion to be set aside for childcare, more debt may follow

Japan's government will set aside $26 billion for new child care measures, slightly more than earlie ...

J&J faces new trial over talc cancer claims, amid settlement push
News

J&J faces new trial over talc cancer claims, amid settlement push

Johnson & Johnson on Wednesday faced the first trial in almost two years over claims that asbest ...

India's Apollo Hospitals reports rise in Q4 profit before tax on lower costs 
Business

India's Apollo Hospitals reports rise in Q4 profit before tax on lower costs 

Indian healthcare services provider Apollo Hospitals Enterprise Ltd reported a 7.6 per cent rise in ...

BioNTech is proceeding with COVID-shot in line with WHO guidance
News

BioNTech is proceeding with COVID-shot in line with WHO guidance

Germany's BioNTech (22UAy.DE) said it was on track to introduce a COVID-19 shot by the early fall in ...

India’s Biocon Biologics says biosimilars put revenue on $1 billion trajectory
News

India’s Biocon Biologics says biosimilars put revenue on $1 billion trajectory

India’s Biocon Biologics closed the year to end-March with revenue on a trajectory towards $1 bill ...

Don't delay reforms to prepare for next pandemic, WHO chief says
News

Don't delay reforms to prepare for next pandemic, WHO chief says

The head of the World Health Organization urged countries on Monday to carry out reforms needed to p ...

Indian labs to give 'top priority' to tests on cough syrup exports - regulator
News

Indian labs to give 'top priority' to tests on cough syrup exports - regulator

India's government laboratories should give "top priority" to testing cough syrup for export, the dr ...

Obesity fighting success fuels Novo bet on gene-editing tech
News

Obesity fighting success fuels Novo bet on gene-editing tech

Capitalising on strong demand for its obesity therapies, Novo Nordisk's (NOVOb.CO) growing appetite ...

India makes tests mandatory for cough syrup export
News

India makes tests mandatory for cough syrup export

India will make tests mandatory for cough syrups before they are exported, a government notice showe ...

WHO 'overstretched' in response to increasing health emergencies
News

WHO 'overstretched' in response to increasing health emergencies

A growing number of health emergencies around the world, from COVID-19 to cholera, have left the Wor ...

India's Glenmark Pharma reports lower Q4 profit as domestic sales weaken
Business

India's Glenmark Pharma reports lower Q4 profit as domestic sales weaken

India's Glenmark Pharmaceuticals Ltd reported a 12.3 per cent decline in fourth-quarter profit on Fr ...

Pfizer to raise $31 billion for Seagen takeover in largest debt offering
News

Pfizer to raise $31 billion for Seagen takeover in largest debt offering

Pfizer Inc (PFE.N) is planning to raise $31 billion through its largest debt offering to f ...

AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
News

AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial

The combination of AstraZeneca's (AZN.L) cancer drug, Tagrisso, with chemotherapy to treat ...

Gene mutations responsible for illness causing heart attack in youngsters: Study
News

Gene mutations responsible for illness causing heart attack in youngsters: Study

The study explores how gene mutations can cause a rare illness leading to cardiac arrests, leading t ...

FTC to block Amgen's deal to acquire Horizon Therapeutics: Report
Business

FTC to block Amgen's deal to acquire Horizon Therapeutics: Report

The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block Amg ...

AstraZeneca to leave leading US drug lobby group
News

AstraZeneca to leave leading US drug lobby group

AstraZeneca (AZN.L) has decided to leave the main US drug lobby group, the Pharmaceutical Research a ...

WHO warns against bias, misinformation in using AI in healthcare
News

WHO warns against bias, misinformation in using AI in healthcare

The World Health Organization called for caution on Tuesday in using artificial intelligence for pub ...

GSK sells $1 bln discounted stake in spin-off Haleon
Business

GSK sells $1 bln discounted stake in spin-off Haleon

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon a ...

Novartis names Sandoz board members ahead of spin-off
News

Novartis names Sandoz board members ahead of spin-off

Novartis on Monday named the intended new board members of Sandoz, the generics business it plans to ...

Siemens Healthineers to stop production of robots - endovascular surgeons
News

Siemens Healthineers to stop production of robots - endovascular surgeons

Siemens Healthineers, a German medical equipment manufacturer, is abandoning its $1 billion acquisit ...

WHO declares end to COVID global health emergency
News

WHO declares end to COVID global health emergency

The World Health Organization ended the global emergency status for COVID-19 on Friday more than thr ...

India's Mankind Pharma soars 32% in rare successful market debut
Business

India's Mankind Pharma soars 32% in rare successful market debut

Shares of India's Mankind Pharma Ltd (MNKI.NS) ended with gains of 31.7% in their trading debut on T ...

Baxter to divest biopharma business for $4.25 billion
News

Baxter to divest biopharma business for $4.25 billion

Baxter International Inc (BAX.N) said on Monday a private-equity group, which includes Warburg Pincu ...

Cash-rich BioNTech broadens scope as COVID shot sales slide
News

Cash-rich BioNTech broadens scope as COVID shot sales slide

Germany's BioNTech 22UAy.DE, Pfizer's PFE.N partner on COVID-19 vaccines, said on Monday its first-q ...

Group of EU states seeks to reduce dependency on China for pharmaceuticals
Business

Group of EU states seeks to reduce dependency on China for pharmaceuticals

A group of 19 European Union member states are pushing for measures to reduce the bloc's dependency ...

US FDA halts India’s Sun Pharma trials on dermatological drug
News

US FDA halts India’s Sun Pharma trials on dermatological drug

The US Food and Drug Administration (FDA) has asked India’s Sun Pharmaceutical Industries Ltd to h ...

Pfizer beats profit estimates on steady COVID products demand
News

Pfizer beats profit estimates on steady COVID products demand

Pfizer Inc on Tuesday beat estimates for first-quarter profit, helped by steady demand for its COVID ...

US FDA approves Pfizer's next-generation pneumococcal vaccine
News

US FDA approves Pfizer's next-generation pneumococcal vaccine

The US Food and Drug Administration (FDA) has approved Pfizer Inc's next-generation vaccine to preve ...

WHO says contaminated cough syrup made in India found in Western Pacific
News

WHO says contaminated cough syrup made in India found in Western Pacific

Contaminated cough syrup made by an Indian company has been found in the Marshall Islands and Micron ...

J&J aims for up to $43 billion valuation for consumer health unit Kenvue
News

J&J aims for up to $43 billion valuation for consumer health unit Kenvue

Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the initi ...

Serum Institute of Life Sciences to double investment in Biocon’s unit to $300 million
News

Serum Institute of Life Sciences to double investment in Biocon’s unit to $300 million

The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd ‘s units, giv ...

US FDA panel backs Innoviva's drug for multidrug-resistant bacterial infections
News

US FDA panel backs Innoviva's drug for multidrug-resistant bacterial infections

A panel of U.S. Food and Drug Administration advisers on Monday unanimously voted in favor of Innovi ...

Nigeria regulator grants approval to Oxford's malaria vaccine
News

Nigeria regulator grants approval to Oxford's malaria vaccine

Nigeria has granted provisional approval to Oxford University's R21 malaria vaccine, its medicines r ...

Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
News

Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return

An experimental mRNA cancer vaccine developed by Moderna Inc (MRNA.O) and Merck & Co&n ...

Merck to buy Prometheus Biosciences in $11 billion deal
News

Merck to buy Prometheus Biosciences in $11 billion deal

US pharmaceutical company Merck & Co will buy Prometheus Biosciences for about $10.8 billion, pi ...

Teva, Viatris win US appeal in patent fight over Parkinson's drug
News

Teva, Viatris win US appeal in patent fight over Parkinson's drug

Belgian biopharmaceutical company UCB (UCB.BR) on Wednesday lost its US court appeal seeking to revi ...

Novavax cut $50 million in costs, plans to slash more, CEO says
News

Novavax cut $50 million in costs, plans to slash more, CEO says

Novavax Inc (NVAX.O) cut about $50 million in costs in the first quarter of 2023 and plans to slash ...

Moderna sees up to $15 bln in respiratory vaccine sales in 2027
News

Moderna sees up to $15 bln in respiratory vaccine sales in 2027

Moderna Inc said on Tuesday it expects sales from its respiratory vaccines to be between $8 billion ...

Hikma Pharma names Mishlawi as next CEO
News

Hikma Pharma names Mishlawi as next CEO

Generic drugmaker Hikma Pharmaceuticals Plc (HIK.L) said on Wednesday Riad Mishlawi, presi ...

U.S. pauses new patients on Merck MS drug in blow to shares
News

U.S. pauses new patients on Merck MS drug in blow to shares

Merck KGaA (MRCG.DE) said on Wednesday the U.S. Food and Drug Administration (FDA) had pau ...

US spending $5 billion to speed up development of new COVID vaccines
News

US spending $5 billion to speed up development of new COVID vaccines

The US government is spending over $5 billion on an effort to speed up the development of new COVID- ...

Glenmark Pharma weighs selling stake in Glenmark Life
News

Glenmark Pharma weighs selling stake in Glenmark Life

India's Glenmark Pharmaceuticals Ltd is considering selling a majority of the 82% stake it holds in ...

US FDA proposes higher bar for accelerated approvals for cancer drugs
News

US FDA proposes higher bar for accelerated approvals for cancer drugs

The US Health regulator on Friday proposed cancer drug developers in most cases conduct more rigorou ...

US to impose inflation fines on first set of drugs, lowering costs
News

US to impose inflation fines on first set of drugs, lowering costs

The US government will subject 27 drugs to inflation penalties, it announced on Wednesday, meaning p ...

US FDA approves Acadia's genetic Rett syndrome drug
News

US FDA approves Acadia's genetic Rett syndrome drug

The U.S. Food and Drug Administration approved Acadia Pharmaceuticals Inc's drug for the treatment o ...

Novartis launches new $11 billion share buyback
News

Novartis launches new $11 billion share buyback

Novartis has formally launched its new share buyback programme where it could spend up to 10 billion ...

U.S. FDA approves Pfizer's nasal spray for migraine
News

U.S. FDA approves Pfizer's nasal spray for migraine

The U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, givi ...

Pfizer in talks to buy cancer drugmaker, Seagen
News

Pfizer in talks to buy cancer drugmaker, Seagen

Pfizer Inc is in earlystage talks to acquire cancer drugmaker Seagen Inc in what could be a multi-bi ...

Biotech firms Redx Pharma and Jounce Therapeutics to merge in $425 mln deal
News

Biotech firms Redx Pharma and Jounce Therapeutics to merge in $425 mln deal

New Delhi: British biotech firm Redx Pharma plc and U.S.- based Jounce Therapeutics Inc will merge t ...

Pfizer and Bayer to keep Russia's drug supply afloat
News

Pfizer and Bayer to keep Russia's drug supply afloat

Pfizer Inc (PFE.N) and Bayer AG (BAYGn.DE) said on Monday that they would continue to supply humanit ...

Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president
News

Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president

New Brunswick: Johnson & Johnson said on Monday John Reed will take the role of executive vice p ...

Abbott to acquire Cardiovascular Systems for $837.6 mln
News

Abbott to acquire Cardiovascular Systems for $837.6 mln

Chicago: Abbott Laboratories said on Wednesday it had agreed to acquire medical device maker Cardiov ...

Carlyle in talks to buy health tech firm Cotiviti for $15 bln
News

Carlyle in talks to buy health tech firm Cotiviti for $15 bln

Hyderabad: Carlyle Group Inc is in talks to buy private healthcare technology firm Cotiviti Inc from ...

Israeli scientists develop sniffing robot with locust antennae
News

Israeli scientists develop sniffing robot with locust antennae

Tel Aviv: A new sniffing robot equipped with a biological sensor that uses the antennae of locu ...

Teresa Graham appointed Roche Pharmaceuticals CEO from March
News

Teresa Graham appointed Roche Pharmaceuticals CEO from March

Berlin: Swiss drugmaker Roche said on Thursday that Teresa Graham has been appointed chief executive ...

BioNTech to invest $43 mln in German facility for mRNA vaccine building block
Business

BioNTech to invest $43 mln in German facility for mRNA vaccine building block

Berlin: BioNTech will invest 40 million euros ($43 million) in a new facility in Germany that will a ...

US FDA removes COVID test requirements for Pfizer, Merck pills
News

US FDA removes COVID test requirements for Pfizer, Merck pills

New York: The US Food and Drug Administration (FDA) on Wednesday removed the need for a positive tes ...

Novavax needs 6 months to produce annual COVID shots that match new variants
News

Novavax needs 6 months to produce annual COVID shots that match new variants

Gaithersburg: Novavax Inc said on Thursday it would require six months to produce a COVID-19 vacc ...

Abbott's medical device sales hit by China curbs, supply chain issues
News

Abbott's medical device sales hit by China curbs, supply chain issues

Bengaluru: Abbott Laboratories on Wednesday reported lower-thanexpected medical device sales for t ...